Dubai, UAE, Feb. 22, 2026 (GLOBE NEWSWIRE) -- Pepeto just crossed $7.285M in presale with three working product demos while most projects in 2026 are still shipping promises. That's not the interesting part. The timing is. Bernstein's Gautam Chhugani put it in writing. Bitcoin to $150,000 this year, cycle peak at $250,000 by 2027 (CoinDesk, January 2026). His team called the $80,000 bottom in November. They were right. Fundstrat's Tom Lee agrees. He said Bitcoin could hit $250,000 once the trend flips (The ...

NEW YORK, Feb. 22, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against AMC Entertainment Holdings, Inc. (NYSE: AMC; APE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AMC Preferred Equity Units (“APEs”) between August 18, 2 ...

Core Viewpoint - Canacol Energy Ltd. is undergoing a leadership change to enhance its restructuring efforts, appointing new interim co-CEOs and an independent director to the board to strengthen its strategic direction during the Companies' Creditors Arrangement Act proceedings [1][2][4]. Leadership Changes - Mr. Jason Bednar and Mr. Ravi Sharma have been appointed as Interim Co-Chief Executive Officers while retaining their roles as Chief Financial Officer and Chief Operating Officer, respectively [2]. - Dr. Charle Gamba has departed from his position as President and Chief Executive Officer, with the board expressing gratitude for his contributions [3]. Board Appointments - Mr. Peter Laurinaitis has been appointed as an independent director, bringing extensive experience in financial restructuring and corporate turnarounds [4][5]. - Laurinaitis has a 30-year background in financial advisory and investment banking, previously serving in senior roles at PJT Partners and Blackstone [6]. Company Overview - Canacol Energy Ltd. is focused on natural gas exploration and production, with operational activities primarily in Colombia [9].

Core Viewpoint - Canacol Energy Ltd. is undergoing a leadership change to enhance its restructuring efforts, with the appointment of interim co-CEOs and an independent director to the board, aimed at positioning the company for success during its restructuring process under the Companies' Creditors Arrangement Act (CCAA) [1][2][4]. Leadership Changes - Mr. Jason Bednar and Mr. Ravi Sharma have been appointed as Interim Co-Chief Executive Officers while retaining their roles as Chief Financial Officer and Chief Operating Officer, respectively [2]. - Dr. Charle Gamba has departed from his role as President and Chief Executive Officer, with the board expressing gratitude for his contributions [3]. Board Appointments - Mr. Peter Laurinaitis has been appointed as an independent director, bringing extensive experience in financial restructuring and corporate turnarounds [4][5]. - Laurinaitis has 30 years of transactional experience and has held significant roles in restructuring at firms like PJT Partners and Blackstone [6]. Company Background - Canacol Energy Ltd. is focused on natural gas exploration and production, primarily operating in Colombia [9].

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.  The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. NEW YORK, Feb. 22, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an ...

PALO ALTO, Calif. and MULGRAVE, Australia, Feb. 22, 2026 (GLOBE NEWSWIRE) -- Gyder Surgical, a MedTech company specializing in intuitive, non-invasive orthopedic navigation solutions, today announced the successful completion of the first commercial surgeries in the United States using the GYDER® Hip Navigation System. The surgeries were performed in Feb 2026, by Dr. Paul M. Lombardi, M.D., a fellowship trained orthopedic surgeon and a well-recognized leader in joint replacement surgeries at the Tri-County ...

Core Viewpoint - nVent Electric plc has postponed its Investor Day originally scheduled for February 24, 2026, due to a state of emergency in the New York metropolitan area caused by an impending winter storm [1][2]. Company Overview - nVent is a global leader in electrical connection and protection solutions, focusing on enabling safer systems and ensuring a secure world through its innovative electrical solutions [3]. - The company designs, manufactures, markets, installs, and services high-performance products that protect sensitive equipment, buildings, and critical processes [3]. - nVent's product portfolio includes well-known brands such as nVent CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF, and TRACHTE, with a history spanning over 100 years [4]. Investor Relations - The company is currently evaluating scheduling options for the postponed Investor Day and will issue a formal invitation once the new date and location are finalized [2]. - The postponement is strictly due to weather-related logistics and does not indicate any changes in the company's operations, financial performance, or outlook [2].

Group 1 - MoonLake Immunotherapeutics announced topline results from the S-OLARIS Phase 2 trial of sonelokimab (SLK) in patients with axial spondyloarthritis (axSpA), demonstrating significant clinical benefits [2][5][6] - In the S-OLARIS trial, 81% of patients treated with SLK achieved an ASAS40 response at Week 12, indicating a clinically meaningful improvement [2][5] - The trial also showed over 80% of patients achieved a clinically important improvement as per ASDAS-CRP score, with significant reductions in inflammation and osteoblast activity observed through PET imaging [2][5][6] Group 2 - MoonLake reported financial results for Q4 and the year ended December 31, 2025, with cash and equivalents totaling $394 million, expected to fund operations into the second half of 2027 [7] - Research and development expenses for Q4 2025 were $56 million, down from $60.6 million in the previous quarter, while general and administrative expenses decreased to $9.2 million from $10.8 million [7] - The company amended its debt facility with Hercules Capital, drawing down $25 million, with up to $400 million in non-dilutive funds available for future needs [7] Group 3 - An Investor Day webcast is scheduled for February 23, 2026, where the company will present the S-OLARIS data and discuss upcoming milestones, including the Type B FDA Meeting outcomes for hidradenitis suppurativa [8][12] - The company is pursuing multiple indications for sonelokimab, including hidradenitis suppurativa, psoriatic arthritis, and palmoplantar pustulosis, with significant market opportunities projected [11][27][29]

Core Insights - Mutuum Finance (MUTM) has raised over $20.6 million in total funds and has more than 19,000 token holders, indicating strong presale momentum and active protocol development [1][3][12] Funding Milestone and Community Growth - The presale has accumulated $20.6 million in contributions, with over 19,000 participants and more than 850 million of the 1.82 billion allocated MUTM tokens already secured [3][4] - Approximately half of the total presale allocation remains available, tightening supply as the project progresses [4] - Currently in Phase 7 of the presale, MUTM is priced at $0.04, reflecting a 300% increase from the initial offering price of $0.01, with a confirmed launch price of $0.06 representing a 500% increase [5][6] Protocol Development and Infrastructure Progress - Mutuum Finance is developing a decentralized lending and borrowing infrastructure based on overcollateralized lending mechanisms [7] - The V1 protocol is live on the Sepolia testnet, allowing users to interact with core components and supported markets like USDT, ETH, LINK, and WBTC [8][9] - The testnet deployment enables participants to explore liquidity provisioning, borrowing, and risk management mechanics ahead of the mainnet transition [9] Security and Roadmap Outlook - The V1 protocol has completed a security audit by Halborn, enhancing confidence in its smart contract framework, while the MUTM token contract has been reviewed by CertiK's Token Scan [10] - Future roadmap objectives include the development of a native overcollateralized stablecoin and plans for multichain expansion [11]

Washington, DC, Feb. 21, 2026 (GLOBE NEWSWIRE) -- ThinkCareBelieve announces a New Report on 57th week of the Trump Administration's Second Term.  The article can be accessed in full at:  https://thinkcarebelieve.blog/2026/02/21/week-57-of-the-trump-2-0-administration/ President Trump making bold moves in the 57th week of his second term.  Setting a global 10% sweeping tariff following the SCOTUS ruling against his use of IEEPA tariffs, he has set a course to correct and overcome any setback before they ha ...